These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34138894)

  • 1. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
    PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
    Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
    Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme.
    Yılmaz H; Niğdelioğlu B; Oktay E; Meydan N
    J Clin Neurosci; 2021 Apr; 86():260-266. PubMed ID: 33775339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
    Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
    BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
    J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.
    Bambury RM; Teo MY; Power DG; Yusuf A; Murray S; Battley JE; Drake C; O'Dea P; Bermingham N; Keohane C; Grossman SA; Moylan EJ; O'Reilly S
    J Neurooncol; 2013 Aug; 114(1):149-54. PubMed ID: 23780645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin.
    Oba T; Maeno K; Ono M; Ito T; Kanai T; Ito KI
    Anticancer Res; 2021 Jan; 41(1):445-452. PubMed ID: 33419842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.
    Mirili C; Yılmaz A; Demirkan S; Bilici M; Basol Tekin S
    Int J Clin Oncol; 2019 Oct; 24(10):1301-1310. PubMed ID: 31073814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
    Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
    Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study.
    Kim YJ; Oh H; Lee SJ; Kim KM; Kang H; Park CK; Park HP
    BMC Cancer; 2021 Aug; 21(1):942. PubMed ID: 34418999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
    Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A
    Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme.
    Mermut O; Inanc B
    Turk Neurosurg; 2020; 30(5):658-665. PubMed ID: 32530473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.
    McNamara MG; Lwin Z; Jiang H; Templeton AJ; Zadeh G; Bernstein M; Chung C; Millar BA; Laperriere N; Mason WP
    J Neurooncol; 2014 Mar; 117(1):147-52. PubMed ID: 24469854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.